APA

Mallick U., Harmer C. & Hackshaw A. (20080912). The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. : Clinical oncology (Royal College of Radiologists (Great Britain)).

Chicago

Mallick U, Harmer C and Hackshaw A. 20080912. The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. : Clinical oncology (Royal College of Radiologists (Great Britain)).

Harvard

Mallick U., Harmer C. and Hackshaw A. (20080912). The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. : Clinical oncology (Royal College of Radiologists (Great Britain)).

MLA

Mallick U, Harmer C and Hackshaw A. The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. : Clinical oncology (Royal College of Radiologists (Great Britain)). 20080912.